Dutch/Swiss biotech company Micreos announced today it has secured its next funding round of €25 million in growth capital and for clinical development of its endolysin technology platform, set to replace
/PRNewswire/ Micreos announced that it has appointed Joost Goderie to the management board as Chief Financial Officer (CFO). Joost will be working closely.
/PRNewswire/ Micreos announced that it has appointed Joost Goderie to the management board as Chief Financial Officer (CFO). Joost will be working closely.
THE HAGUE, The Netherlands, Jan. 28, 2022 /PRNewswire/ Micreos announced that it has appointed Joost Goderie to the management board as Chief Financial Officer (CFO). Joost will be working closely together with the other members of the management team to help drive Micreos s growth and deliver its targeted antibacterial technology to the world. He will be responsible for Finance, Tax and Legal, and will coordinate the company s legal restructuring, which will result in the separation of its pharma and OTC businesses.
Joost brings over 30 years of finance and leadership experience in various CFO and general management roles and has extensive experience in building and growing businesses. He was formerly CFO and CEO of Eurofiber, a European fiber optic communication provider, that he co-founded in 2000 and was one of the initiators and Managing Director of Rabo s Bouwfonds Communication Infrastructure Fund.
Micreos CEO Mark Offerhaus said: "We are very pleased to welcome Joo